PERSPECTIVE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 67.76 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-03-16
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2023-12-31 was 1.24M shares.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2023-09-30 was 389.60K shares, a 128.74% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2023-06-30 was 808.30K shares, a 467.29% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2023-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 67.76K shares, a 7.77% increase from fiscal 2024.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 62.88K shares, a 97.42% decline from fiscal 2023.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 2.43M shares.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 256.06K shares, a 71.39% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | 67.76K shares 10-K · filed 2026-03-16 | ||||
| 2024-12-31 | 62.88K shares 10-K/A · filed 2025-03-28 | ||||
| 2023-12-31 | 1.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 1.63M shares derived: sum of 2 quarters · filed 2024-03-28 | 2.43M shares derived: sum of 3 quarters · filed 2024-03-28 | 2.43M shares 10-K · filed 2024-03-28 | |
| 2023-09-30 | 389.60K shares 10-Q · filed 2023-11-14 | 1.20M shares derived: sum of 2 quarters · filed 2023-11-14 | 1.20M shares 10-Q · filed 2023-11-14 | 1.20M shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-06-30 | 808.30K shares 10-Q · filed 2023-08-11 | 808.30K shares 10-Q · filed 2023-08-11 | 808.30K shares derived: sum of 3 quarters · filed 2024-03-28 | 978.63K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-28 | 170.32K shares derived: sum of 3 quarters · filed 2024-03-28 | 312.81K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-12-31 | 0.00 shares derived: 10-K 6 month − 10-Q 3 month · filed 2024-03-28 | 170.32K shares 10-K · filed 2024-03-28 | 312.81K shares derived: sum of 3 quarters · filed 2024-03-28 | 426.38K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-09-30 | 170.32K shares 10-Q · filed 2023-11-14 | 312.81K shares derived: sum of 2 quarters · filed 2023-11-14 | 396.88K shares 10-Q · filed 2023-11-14 | 448.38K shares derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | 142.49K shares 10-Q · filed 2023-08-11 | 226.56K shares 10-Q · filed 2023-08-11 | 278.06K shares derived: sum of 3 quarters · filed 2023-08-11 | 256.06K shares 10-K · filed 2024-03-28 | |
| 2022-03-31 | 113.58K shares 10-Q · filed 2023-05-15 | 84.08K shares 10-Q · filed 2022-05-13 | 135.57K shares derived: sum of 2 quarters · filed 2023-05-15 | 113.58K shares 10-Q · filed 2022-05-13 | 288.48K shares derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 22.00K shares 10-Q · filed 2022-02-09 | 29.50K shares 10-Q · filed 2022-02-09 | 174.91K shares derived: sum of 3 quarters · filed 2023-05-01 | 176.91K shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2021-09-30 | 7.50K shares 10-Q · filed 2022-11-14 | 152.91K shares derived: sum of 2 quarters · filed 2023-05-01 | 154.91K shares derived: sum of 3 quarters · filed 2023-05-01 | 154.91K shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2021-06-30 | 145.41K shares derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | 147.41K shares derived: sum of 2 quarters · filed 2023-05-01 | 147.41K shares derived: sum of 3 quarters · filed 2023-05-01 | 149.41K shares 10-KT · filed 2023-05-01 | |
| 2021-03-31 | 2.00K shares 10-Q · filed 2022-05-13 | 2.00K shares derived: sum of 2 quarters · filed 2022-05-13 | 4.00K shares 10-Q · filed 2022-05-13 | 167.31K shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-12-31 | 0.00 shares 10-Q · filed 2022-02-09 | 2.00K shares 10-Q · filed 2022-02-09 | 165.31K shares derived: sum of 3 quarters · filed 2023-05-01 | 186.56K shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-09-30 | 2.00K shares 10-Q · filed 2021-11-10 | 165.31K shares derived: sum of 2 quarters · filed 2023-05-01 | 186.56K shares derived: sum of 3 quarters · filed 2023-05-01 | 186.56K shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-06-30 | 163.31K shares derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | 184.56K shares derived: sum of 2 quarters · filed 2023-05-01 | 184.56K shares derived: sum of 3 quarters · filed 2023-05-01 | 192.81K shares 10-KT · filed 2023-05-01 | |
| 2020-03-31 | 21.25K shares 10-Q · filed 2021-05-14 | 21.25K shares derived: sum of 2 quarters · filed 2021-05-14 | 29.50K shares 10-Q · filed 2021-05-14 | 251.50K shares derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-12-31 | 0.00 shares 10-Q · filed 2021-02-09 | 8.25K shares 10-Q · filed 2021-02-09 | 230.25K shares derived: sum of 3 quarters · filed 2021-09-27 | 240.25K shares derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-09-30 | 8.25K shares 10-Q · filed 2020-11-13 | 230.25K shares derived: sum of 2 quarters · filed 2021-09-27 | 240.25K shares derived: sum of 3 quarters · filed 2021-09-27 | 240.25K shares derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-06-30 | 222.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27 | 232.00K shares derived: sum of 2 quarters · filed 2021-09-27 | 232.00K shares derived: sum of 3 quarters · filed 2021-09-27 | 242.00K shares 10-K · filed 2021-09-27 | |
| 2019-03-31 | 10.00K shares 10-Q · filed 2020-05-13 | 10.00K shares derived: sum of 2 quarters · filed 2020-05-13 | 20.00K shares 10-Q · filed 2020-05-13 | 120.00K shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-12-31 | 0.00 shares 10-Q · filed 2020-02-12 | 10.00K shares 10-Q · filed 2020-02-12 | 110.00K shares derived: sum of 3 quarters · filed 2020-09-25 | 110.00K shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-09-30 | 10.00K shares 10-Q · filed 2019-11-13 | 110.00K shares derived: sum of 2 quarters · filed 2020-09-25 | 110.00K shares derived: sum of 3 quarters · filed 2020-09-25 | 110.00K shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-06-30 | 100.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | 100.00K shares derived: sum of 2 quarters · filed 2020-09-25 | 100.00K shares derived: sum of 3 quarters · filed 2020-09-25 | 100.00K shares 10-K · filed 2020-09-25 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-05-10 | 0.00 shares derived: sum of 2 quarters · filed 2019-05-10 | 0.00 shares 10-Q · filed 2019-05-10 | 206.87K shares derived: sum of 4 quarters · filed 2019-09-27 | |
| 2017-12-31 | 0.00 shares 10-Q · filed 2019-02-13 | 0.00 shares 10-Q · filed 2019-02-13 | 206.87K shares derived: sum of 3 quarters · filed 2019-09-27 | 229.37K shares derived: sum of 4 quarters · filed 2019-09-27 | |
| 2017-09-30 | 0.00 shares 10-Q · filed 2018-11-09 | 206.87K shares derived: sum of 2 quarters · filed 2019-09-27 | 229.37K shares derived: sum of 3 quarters · filed 2019-09-27 | 229.37K shares derived: sum of 4 quarters · filed 2019-09-27 | |
| 2017-06-30 | 206.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | 229.37K shares derived: sum of 2 quarters · filed 2019-09-27 | 229.37K shares derived: sum of 3 quarters · filed 2019-09-27 | 509.90K shares 10-K · filed 2019-09-27 | |
| 2017-03-31 | 22.50K shares 10-Q · filed 2018-05-04 | 22.50K shares derived: sum of 2 quarters · filed 2018-05-04 | 303.03K shares 10-Q · filed 2018-05-04 | ||
| 2016-12-31 | 0.00 shares 10-Q · filed 2018-02-09 | 280.53K shares 10-Q · filed 2018-02-09 | |||
| 2016-09-30 | 280.53K shares 10-Q · filed 2017-11-14 | ||||
| 2016-06-30 | 459.59K shares 10-K · filed 2018-09-26 | ||||
| 2014-12-31 | 39.00K shares 10-Q · filed 2015-02-17 | ||||
| 2014-06-30 | 19.67K shares 10-K · filed 2014-09-29 | ||||
| 2013-06-30 | 37.53K shares 10-K · filed 2014-09-29 | ||||
| 2012-06-30 | 132.90K shares 10-K · filed 2013-09-30 | ||||
| 2011-06-30 | 133.27K shares 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |